Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that Chief Executive Officer, President and Chairman Kevin Hrusovsky will present at the 19th Annual Needham Healthcare Conference, on April 14, at 11:20 a.m., EDT. The live webcast will be available in the Investor section of the Quanterix website at http://www.quanterix.com. Replays of the webcast will be available on the Quanterix website for 90 days following the conference.
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]
Quanterix announced that it has successfully applied its Simoa® technology to achieve a 100x sensitivity improvement.
Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it will release its financial results for first quarter 2020 after the close of trading on Tuesday, May 5, 2020. Company management will host a conference call at 4:30 p.m., EDT to discuss Quanterix’ financial results and provide a business update. The call will be hosted by Kevin Hrusovsky, Chief Executive Officer, President and Chairman, Quanterix.
Researchers Develop Breakthrough COVID-19 Antibody Test with 1,000-Fold Sensitivity Improvement Using Quanterix’ Simoa Technology.
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the third quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
Last week, you might have seen that Quanterix Corporation (NASDAQ:QTRX) released its first-quarter result to the...
Quanterix (QTRX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Quanterix Corporation Releases Operating Results for First Quarter 2020
Quanterix CEO Kevin Hrusovsky, also the founder of the Powering Precision Health (PPH) network, will appear on Passionate Pioneers with Mike Biselli
Quanterix Corporation announced financial results for the fourth quarter and 12 months ended December 31, 2019.
Quanterix Announces Simoa® Success Grant Program to Accelerate Promising Infectious Disease & Immunology Research
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
If you're interested in Quanterix Corporation (NASDAQ:QTRX), then you might want to consider its beta (a measure of...
With me on today's call is Kevin Hrusovsky, our CEO, president and chairman. Today's call will contain forward-looking statements that are based on management's beliefs and assumptions and information available as of the date of this call. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced the following statement amid the continued COVID-19 global crisis, severely impacting public health and the economy.
Quanterix Corporation (NASDAQ: QTRX), a company revolutionizing digital biomarkers, joined forces with PPH in the fight against COVID-19. The first session, in a series of Think Tank Webinars designed to stimulate and catalyze biomarker innovations, was held on April 2, 2020 with world leading virology and epidemiology experts. This follows closely behind the company’s recent disclosure of its safety-first resiliency plan; the introduction of a robust set of products, applications and services directly aimed at supporting COVID-19 investigators.
It's been a sad week for Quanterix Corporation (NASDAQ:QTRX), who've watched their investment drop 17% to US$19.78 in...